重仓股明细
查询指定年度的基金持仓:
| 季报日期: 2026-03-31 |
| 序号 |
股票代码 |
股票名称 |
占净值比例 |
持股数量(万股) |
持股市值(万元) |
占股票市值比例(季报) |
持仓变动 |
| 1 |
603259 |
药明康德 |
8.87% |
105.94 |
10392.83 |
0.04% |
-4.70 (-4.44%) |
| 2 |
06990 |
科伦博泰生物 |
8.53% |
24.60 |
9991.46 |
0.15% |
-7.76 (-31.54%) |
| 3 |
01801 |
信达生物 |
8.43% |
131.65 |
9868.81 |
0.08% |
-5.45 (-4.14%) |
| 4 |
02268 |
药明合联 |
5.87% |
133.85 |
6878.24 |
0.11% |
-59.90 (-44.75%) |
| 5 |
600276 |
恒瑞医药 |
5.49% |
116.49 |
6432.77 |
0.02% |
-0.43 (-0.37%) |
| 6 |
002821 |
凯莱英 |
5.18% |
54.71 |
6060.64 |
0.17% |
-19.68 (-35.96%) |
| 7 |
02269 |
药明生物 |
4.79% |
192.37 |
5608.60 |
0.05% |
-185.15 (-96.25%) |
| 8 |
300347 |
泰格医药 |
4.77% |
103.73 |
5583.91 |
0.18% |
-11.76 (-11.34%) |
| 9 |
300759 |
康龙化成 |
4.67% |
195.37 |
5466.31 |
0.14% |
-35.34 (-18.09%) |
| 10 |
688046 |
药康生物 |
3.88% |
313.51 |
4539.63 |
0.76% |
新增 |
| 季报日期: 2026-03-31 |
| 序号 |
股票代码 |
股票名称 |
占净值比例 |
持股数量(万股) |
持股市值(万元) |
占股票市值比例(季报) |
持仓变动 |
| 1 |
603259 |
药明康德 |
8.87% |
105.94 |
10392.83 |
0.04% |
-4.70 (-4.44%) |
| 2 |
06990 |
科伦博泰生物 |
8.53% |
24.60 |
9991.46 |
0.15% |
-7.76 (-31.54%) |
| 3 |
01801 |
信达生物 |
8.43% |
131.65 |
9868.81 |
0.08% |
-5.45 (-4.14%) |
| 4 |
02268 |
药明合联 |
5.87% |
133.85 |
6878.24 |
0.11% |
-59.90 (-44.75%) |
| 5 |
600276 |
恒瑞医药 |
5.49% |
116.49 |
6432.77 |
0.02% |
-0.43 (-0.37%) |
| 6 |
002821 |
凯莱英 |
5.18% |
54.71 |
6060.64 |
0.17% |
-19.68 (-35.96%) |
| 7 |
02269 |
药明生物 |
4.79% |
192.37 |
5608.60 |
0.05% |
-185.15 (-96.25%) |
| 8 |
300347 |
泰格医药 |
4.77% |
103.73 |
5583.91 |
0.18% |
-11.76 (-11.34%) |
| 9 |
300759 |
康龙化成 |
4.67% |
195.37 |
5466.31 |
0.14% |
-35.34 (-18.09%) |
| 10 |
688046 |
药康生物 |
3.88% |
313.51 |
4539.63 |
0.76% |
新增 |
| 11 |
03347 |
泰格医药 |
1.92% |
61.36 |
2245.13 |
0.50% |
--- |
| 12 |
06821 |
凯莱英 |
0.51% |
7.41 |
595.38 |
0.27% |
--- |
显示全部持仓明细>>
| 季报日期: 2025-12-31 |
| 序号 |
股票代码 |
股票名称 |
占净值比例 |
持股数量(万股) |
持股市值(万元) |
占股票市值比例(季报) |
持仓变动 |
| 1 |
06990 |
科伦博泰生物 |
8.64% |
32.36 |
11463.30 |
0.20% |
新增 |
| 2 |
02269 |
药明生物 |
8.08% |
377.52 |
10720.57 |
0.09% |
新增 |
| 3 |
02268 |
药明合联 |
8.02% |
193.75 |
10631.18 |
0.15% |
新增 |
| 4 |
603259 |
药明康德 |
7.56% |
110.64 |
10028.52 |
0.04% |
新增 |
| 5 |
01801 |
信达生物 |
7.12% |
137.10 |
9442.15 |
0.08% |
8.39 (6.12%) |
| 6 |
600276 |
恒瑞医药 |
5.25% |
116.92 |
6965.13 |
0.02% |
新增 |
| 7 |
002821 |
凯莱英 |
5.21% |
74.39 |
6913.03 |
0.23% |
新增 |
| 8 |
300759 |
康龙化成 |
4.95% |
230.71 |
6558.94 |
0.16% |
新增 |
| 9 |
300347 |
泰格医药 |
4.94% |
115.49 |
6548.41 |
0.20% |
新增 |
| 10 |
688235 |
百济神州 |
4.00% |
19.73 |
5299.67 |
0.17% |
新增 |
| 季报日期: 2025-12-31 |
| 序号 |
股票代码 |
股票名称 |
占净值比例 |
持股数量(万股) |
持股市值(万元) |
占股票市值比例(季报) |
持仓变动 |
| 1 |
06990 |
科伦博泰生物 |
8.64% |
32.36 |
11463.30 |
0.20% |
新增 |
| 2 |
02269 |
药明生物 |
8.08% |
377.52 |
10720.57 |
0.09% |
新增 |
| 3 |
02268 |
药明合联 |
8.02% |
193.75 |
10631.18 |
0.15% |
新增 |
| 4 |
603259 |
药明康德 |
7.56% |
110.64 |
10028.52 |
0.04% |
新增 |
| 5 |
01801 |
信达生物 |
7.12% |
137.10 |
9442.15 |
0.08% |
8.39 (6.12%) |
| 6 |
600276 |
恒瑞医药 |
5.25% |
116.92 |
6965.13 |
0.02% |
新增 |
| 7 |
002821 |
凯莱英 |
5.21% |
74.39 |
6913.03 |
0.23% |
新增 |
| 8 |
300759 |
康龙化成 |
4.95% |
230.71 |
6558.94 |
0.16% |
新增 |
| 9 |
300347 |
泰格医药 |
4.94% |
115.49 |
6548.41 |
0.20% |
新增 |
| 10 |
688235 |
百济神州 |
4.00% |
19.73 |
5299.67 |
0.17% |
新增 |
| 11 |
06160 |
百济神州 |
3.39% |
27.74 |
4492.42 |
0.02% |
--- |
| 12 |
03347 |
泰格医药 |
1.94% |
67.11 |
2578.57 |
0.55% |
--- |
| 13 |
06821 |
凯莱英 |
1.77% |
36.55 |
2350.50 |
1.33% |
--- |
| 14 |
03759 |
康龙化成 |
1.44% |
107.70 |
1905.65 |
0.37% |
--- |
显示全部持仓明细>>
| 季报日期: 2024-06-30 |
| 序号 |
股票代码 |
股票名称 |
占净值比例 |
持股数量(万股) |
持股市值(万元) |
占股票市值比例(季报) |
持仓变动 |
| 1 |
01801 |
信达生物 |
5.03% |
128.71 |
4322.86 |
5.74% |
71.70 (55.71%) |
| 2 |
01548 |
金斯瑞生物科技 |
4.28% |
483.80 |
3673.73 |
4.88% |
272.20 (56.26%) |
| 季报日期: 2024-06-30 |
| 序号 |
股票代码 |
股票名称 |
占净值比例 |
持股数量(万股) |
持股市值(万元) |
占股票市值比例(季报) |
持仓变动 |
| 1 |
01801 |
信达生物 |
5.03% |
128.71 |
4322.86 |
5.74% |
71.70 (55.71%) |
| 2 |
01548 |
金斯瑞生物科技 |
4.28% |
483.80 |
3673.73 |
4.88% |
272.20 (56.26%) |
显示全部持仓明细>>
| 季报日期: 2023-12-31 |
| 序号 |
股票代码 |
股票名称 |
占净值比例 |
持股数量(万股) |
持股市值(万元) |
占股票市值比例(季报) |
持仓变动 |
| 1 |
01548 |
金斯瑞生物科技 |
3.46% |
211.60 |
3808.28 |
3.81% |
0.00 (0.00%) |
| 2 |
09995 |
荣昌生物 |
3.39% |
110.15 |
3738.26 |
3.74% |
40.75 (36.99%) |
| 3 |
02269 |
药明生物 |
2.79% |
114.37 |
3067.92 |
3.07% |
73.70 (64.44%) |
| 4 |
06618 |
京东健康 |
2.26% |
70.41 |
2494.67 |
2.50% |
0.00 (0.00%) |
| 5 |
01099 |
国药控股 |
2.13% |
126.88 |
2351.37 |
2.36% |
2.20 (1.73%) |
| 6 |
01801 |
信达生物 |
2.01% |
57.01 |
2208.53 |
2.21% |
0.80 (1.40%) |
| 7 |
02171 |
科济药业-B |
0.74% |
138.85 |
817.89 |
0.82% |
0.00 (0.00%) |
| 8 |
01515 |
华润医疗 |
0.64% |
162.00 |
707.61 |
0.71% |
0.00 (0.00%) |
| 9 |
00013 |
和黄医药 |
0.04% |
1.50 |
39.01 |
0.04% |
新增 |
| 10 |
02186 |
绿叶制药 |
0.03% |
11.30 |
38.20 |
0.04% |
新增 |
| 季报日期: 2023-12-31 |
| 序号 |
股票代码 |
股票名称 |
占净值比例 |
持股数量(万股) |
持股市值(万元) |
占股票市值比例(季报) |
持仓变动 |
| 1 |
01548 |
金斯瑞生物科技 |
3.46% |
211.60 |
3808.28 |
3.81% |
0.00 (0.00%) |
| 2 |
09995 |
荣昌生物 |
3.39% |
110.15 |
3738.26 |
3.74% |
40.75 (36.99%) |
| 3 |
02269 |
药明生物 |
2.79% |
114.37 |
3067.92 |
3.07% |
73.70 (64.44%) |
| 4 |
06618 |
京东健康 |
2.26% |
70.41 |
2494.67 |
2.50% |
0.00 (0.00%) |
| 5 |
01099 |
国药控股 |
2.13% |
126.88 |
2351.37 |
2.36% |
2.20 (1.73%) |
| 6 |
01801 |
信达生物 |
2.01% |
57.01 |
2208.53 |
2.21% |
0.80 (1.40%) |
| 7 |
02171 |
科济药业-B |
0.74% |
138.85 |
817.89 |
0.82% |
0.00 (0.00%) |
| 8 |
01515 |
华润医疗 |
0.64% |
162.00 |
707.61 |
0.71% |
0.00 (0.00%) |
| 9 |
00013 |
和黄医药 |
0.04% |
1.50 |
39.01 |
0.04% |
新增 |
| 10 |
02186 |
绿叶制药 |
0.03% |
11.30 |
38.20 |
0.04% |
新增 |
| 11 |
00867 |
康哲药业 |
0.02% |
2.10 |
26.34 |
0.03% |
--- |
显示全部持仓明细>>
| 季报日期: 2023-06-30 |
| 序号 |
股票代码 |
股票名称 |
占净值比例 |
持股数量(万股) |
持股市值(万元) |
占股票市值比例(季报) |
持仓变动 |
| 1 |
01548 |
金斯瑞生物科技 |
2.91% |
211.60 |
3433.60 |
3.28% |
0.00 (0.00%) |
| 2 |
06618 |
京东健康 |
2.72% |
70.41 |
3209.90 |
3.07% |
新增 |
| 3 |
01099 |
国药控股 |
2.38% |
124.68 |
2816.34 |
2.69% |
57.56 (46.17%) |
| 4 |
09995 |
荣昌生物 |
1.85% |
69.40 |
2191.50 |
2.10% |
16.85 (24.28%) |
| 5 |
01801 |
信达生物 |
1.30% |
56.21 |
1533.94 |
1.47% |
0.00 (0.00%) |
| 6 |
02269 |
药明生物 |
1.19% |
40.67 |
1408.06 |
1.35% |
-31.95 (-78.56%) |
| 7 |
02171 |
科济药业-B |
1.05% |
138.85 |
1240.48 |
1.19% |
0.00 (0.00%) |
| 8 |
01515 |
华润医疗 |
0.76% |
162.00 |
897.66 |
0.86% |
新增 |
| 季报日期: 2023-06-30 |
| 序号 |
股票代码 |
股票名称 |
占净值比例 |
持股数量(万股) |
持股市值(万元) |
占股票市值比例(季报) |
持仓变动 |
| 1 |
01548 |
金斯瑞生物科技 |
2.91% |
211.60 |
3433.60 |
3.28% |
0.00 (0.00%) |
| 2 |
06618 |
京东健康 |
2.72% |
70.41 |
3209.90 |
3.07% |
新增 |
| 3 |
01099 |
国药控股 |
2.38% |
124.68 |
2816.34 |
2.69% |
57.56 (46.17%) |
| 4 |
09995 |
荣昌生物 |
1.85% |
69.40 |
2191.50 |
2.10% |
16.85 (24.28%) |
| 5 |
01801 |
信达生物 |
1.30% |
56.21 |
1533.94 |
1.47% |
0.00 (0.00%) |
| 6 |
02269 |
药明生物 |
1.19% |
40.67 |
1408.06 |
1.35% |
-31.95 (-78.56%) |
| 7 |
02171 |
科济药业-B |
1.05% |
138.85 |
1240.48 |
1.19% |
0.00 (0.00%) |
| 8 |
01515 |
华润医疗 |
0.76% |
162.00 |
897.66 |
0.86% |
新增 |
显示全部持仓明细>>
| 季报日期: 2022-12-31 |
| 序号 |
股票代码 |
股票名称 |
占净值比例 |
持股数量(万股) |
持股市值(万元) |
占股票市值比例(季报) |
持仓变动 |
| 1 |
01548 |
金斯瑞生物科技 |
3.80% |
211.60 |
4697.05 |
4.12% |
45.20 (21.36%) |
| 2 |
02269 |
药明生物 |
3.14% |
72.62 |
3882.51 |
3.41% |
22.00 (30.29%) |
| 3 |
09995 |
荣昌生物-B |
2.20% |
52.55 |
2717.90 |
2.39% |
52.40 (99.71%) |
| 4 |
02171 |
科济药业-B |
1.50% |
138.85 |
1857.98 |
1.63% |
70.10 (50.49%) |
| 5 |
01801 |
信达生物 |
1.36% |
56.21 |
1681.99 |
1.48% |
-56.20 (-99.99%) |
| 6 |
01099 |
国药控股 |
0.96% |
67.12 |
1189.53 |
1.04% |
新增 |
| 季报日期: 2022-12-31 |
| 序号 |
股票代码 |
股票名称 |
占净值比例 |
持股数量(万股) |
持股市值(万元) |
占股票市值比例(季报) |
持仓变动 |
| 1 |
01548 |
金斯瑞生物科技 |
3.80% |
211.60 |
4697.05 |
4.12% |
45.20 (21.36%) |
| 2 |
02269 |
药明生物 |
3.14% |
72.62 |
3882.51 |
3.41% |
22.00 (30.29%) |
| 3 |
09995 |
荣昌生物-B |
2.20% |
52.55 |
2717.90 |
2.39% |
52.40 (99.71%) |
| 4 |
02171 |
科济药业-B |
1.50% |
138.85 |
1857.98 |
1.63% |
70.10 (50.49%) |
| 5 |
01801 |
信达生物 |
1.36% |
56.21 |
1681.99 |
1.48% |
-56.20 (-99.99%) |
| 6 |
01099 |
国药控股 |
0.96% |
67.12 |
1189.53 |
1.04% |
新增 |
显示全部持仓明细>>
| 季报日期: 2022-06-30 |
| 序号 |
股票代码 |
股票名称 |
占净值比例 |
持股数量(万股) |
持股市值(万元) |
占股票市值比例(季报) |
持仓变动 |
| 1 |
01548 |
金斯瑞生物科技 |
3.35% |
166.40 |
4048.54 |
3.71% |
新增 |
| 2 |
01801 |
信达生物 |
2.77% |
112.41 |
3354.93 |
3.07% |
39.15 (34.83%) |
| 3 |
02269 |
药明生物 |
2.57% |
50.62 |
3108.30 |
2.85% |
-20.55 (-40.60%) |
| 4 |
02171 |
科济药业-B |
0.71% |
68.75 |
859.57 |
0.79% |
新增 |
| 5 |
09995 |
荣昌生物-B |
0.00% |
0.15 |
5.64 |
0.01% |
新增 |
| 季报日期: 2022-06-30 |
| 序号 |
股票代码 |
股票名称 |
占净值比例 |
持股数量(万股) |
持股市值(万元) |
占股票市值比例(季报) |
持仓变动 |
| 1 |
01548 |
金斯瑞生物科技 |
3.35% |
166.40 |
4048.54 |
3.71% |
新增 |
| 2 |
01801 |
信达生物 |
2.77% |
112.41 |
3354.93 |
3.07% |
39.15 (34.83%) |
| 3 |
02269 |
药明生物 |
2.57% |
50.62 |
3108.30 |
2.85% |
-20.55 (-40.60%) |
| 4 |
02171 |
科济药业-B |
0.71% |
68.75 |
859.57 |
0.79% |
新增 |
| 5 |
09995 |
荣昌生物-B |
0.00% |
0.15 |
5.64 |
0.01% |
新增 |
显示全部持仓明细>>
| 季报日期: 2021-06-30 |
| 序号 |
股票代码 |
股票名称 |
占净值比例 |
持股数量(万股) |
持股市值(万元) |
占股票市值比例(季报) |
持仓变动 |
| 1 |
02269 |
药明生物 |
9.65% |
71.17 |
8427.07 |
10.58% |
--- |
| 2 |
06078 |
海吉亚医疗 |
9.63% |
99.05 |
8406.83 |
10.56% |
--- |
| 3 |
01801 |
信达生物 |
6.32% |
73.26 |
5519.59 |
6.93% |
--- |
| 4 |
01521 |
方达控股 |
1.00% |
127.40 |
874.56 |
1.10% |
--- |
| 5 |
01873 |
维亚生物 |
0.87% |
91.45 |
756.37 |
0.95% |
--- |
| 季报日期: 2021-06-30 |
| 序号 |
股票代码 |
股票名称 |
占净值比例 |
持股数量(万股) |
持股市值(万元) |
占股票市值比例(季报) |
持仓变动 |
| 1 |
02269 |
药明生物 |
9.65% |
71.17 |
8427.07 |
10.58% |
--- |
| 2 |
06078 |
海吉亚医疗 |
9.63% |
99.05 |
8406.83 |
10.56% |
--- |
| 3 |
01801 |
信达生物 |
6.32% |
73.26 |
5519.59 |
6.93% |
--- |
| 4 |
01521 |
方达控股 |
1.00% |
127.40 |
874.56 |
1.10% |
--- |
| 5 |
01873 |
维亚生物 |
0.87% |
91.45 |
756.37 |
0.95% |
--- |
显示全部持仓明细>>